PMID- 35387024 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230127 IS - 2673-6101 (Electronic) IS - 2673-6101 (Print) IS - 2673-6101 (Linking) VI - 2 DP - 2021 TI - When the Frequencies of Sensitization and Elicitation of Allergic Reaction Do Not Correlate-The Case of Apple Gibberellin-Regulated Protein Tested in an Italian Population. PG - 745825 LID - 10.3389/falgy.2021.745825 [doi] LID - 745825 AB - Background: The literature reports describing allergic symptoms against apples in the patients sensitized to the gibberellin-regulated proteins (GRPs) suggested the presence of an allergenic GRP in this fruit. Objective: This study aimed to assess the presence of a GRP protein in apples and investigate its allergenicity. Methods: The protein was isolated and identified by the classical biochemical methods. The bioinformatics tools were used for similar searches and molecular modeling. The immunological features were investigated using the multiplex FABER test. Clinical data were collected by the allergy specialists. Results: A GRP was detected in the apple peel and pulp and it was named applemaclein. This protein displays 94% of sequence identity with peamaclein, Pru p 7, representing the prototype of this allergen family. The applemaclein molecular model shows a very irregular surface with grooves/clefts that may potentially accommodate small molecular ligands. In a population of 4,721 patients in Italy, 187 (4.0%) were sensitized to any allergenic GPR. Of those, 115 (61.5%), 61 (32.6%), 30 (16.0%), and 99 (52.9%) had immunoglobulin E (IgE) to apple, peach, pomegranate, and cypress GRP, respectively. However, in a cohort of the patients in Italy, most individuals IgE positive to the apple GRP did not report allergic reactions against this fruit. Conclusion: Compared with the peach Pru p 7, applemaclein shows some different structural features and higher sensitization frequency, which is often not associated with allergic reactions against apple. Further studies are needed to understand a possible correlation between the applemaclein structural properties, the interaction with still unknown molecules, and immunological behavior. CI - Copyright (c) 2021 Tuppo, Alessandri, Giangrieco, Tamburrini, Arriaza, Chruszcz, Mari and Ciardiello. FAU - Tuppo, Lisa AU - Tuppo L AD - Institute of Biosciences and BioResources (IBBR), CNR, Naples, Italy. AD - Allergy Data Laboratories (ADL) S.r.l., Latina, Italy. FAU - Alessandri, Claudia AU - Alessandri C AD - Allergy Data Laboratories (ADL) S.r.l., Latina, Italy. AD - Associated Centers for Molecular Allergology (CAAM), Rome, Italy. FAU - Giangrieco, Ivana AU - Giangrieco I AD - Institute of Biosciences and BioResources (IBBR), CNR, Naples, Italy. AD - Allergy Data Laboratories (ADL) S.r.l., Latina, Italy. FAU - Tamburrini, Maurizio AU - Tamburrini M AD - Institute of Biosciences and BioResources (IBBR), CNR, Naples, Italy. FAU - Arriaza, Ricardo Hernandez AU - Arriaza RH AD - Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, United States. FAU - Chruszcz, Maksymilian AU - Chruszcz M AD - Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, United States. FAU - Mari, Adriano AU - Mari A AD - Allergy Data Laboratories (ADL) S.r.l., Latina, Italy. AD - Associated Centers for Molecular Allergology (CAAM), Rome, Italy. FAU - Ciardiello, Maria Antonietta AU - Ciardiello MA AD - Institute of Biosciences and BioResources (IBBR), CNR, Naples, Italy. LA - eng GR - R01 AI077653/AI/NIAID NIH HHS/United States PT - Journal Article DEP - 20211021 PL - Switzerland TA - Front Allergy JT - Frontiers in allergy JID - 9918227355906676 PMC - PMC8974745 OTO - NOTNLM OT - IgE-binding OT - Pru p 7 OT - apple GRP OT - applemaclein OT - applemaclein molecular model OT - food allergy OT - sensitization frequency COIS- IG and LT were employees of ADL s.r.l. when this study started, currently they are employees of IBBR-CNR. MT and MAC receive funding from ADL s.r.l. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/04/08 06:00 MHDA- 2022/04/08 06:01 PMCR- 2021/10/21 CRDT- 2022/04/07 05:20 PHST- 2021/07/22 00:00 [received] PHST- 2021/09/22 00:00 [accepted] PHST- 2022/04/07 05:20 [entrez] PHST- 2022/04/08 06:00 [pubmed] PHST- 2022/04/08 06:01 [medline] PHST- 2021/10/21 00:00 [pmc-release] AID - 10.3389/falgy.2021.745825 [doi] PST - epublish SO - Front Allergy. 2021 Oct 21;2:745825. doi: 10.3389/falgy.2021.745825. eCollection 2021.